CD274 and neoplasm: Moreover, we evaluated the effects of circCFL1 shRNA on anti‐PD‐L1 therapy by in vivo experiments, which demonstrated that circCFL1 shRNA combined with anti‐PD‐L1 could significantly decrease tumor size.